Atazanavir + cobicistat (Evotaz)

Status:
Red
Decision Date:
November 2021
 

Comments

RED: Use in combination with other antiretroviral medicinal products for the treatment of HIV-1 infected adults and adolescents (aged ≥12 years weighing ≥35 kg) without known mutations associated with resistance to atazanavir. 

Red Drug Classifications

  • 8. NHS England commissioned – to be used in line with NHSE commissioning intentions

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app